% alzhub.org topic: ratio
% Source: https://alzhub.org/topic/ratio
% 26 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{figdore2025-40308118,
  author  = {Figdore, D. J. and Schuder, B. J. and Ashrafzadeh-Kian, S. and Gronquist, T. and Bornhorst, J. A. and Algeciras-Schimnich, A.},
  title   = {{Differences in Alzheimer's disease blood biomarker stability: Implications for the use of tau/amyloid ratios}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2025},
  doi     = {10.1002/alz.70173},
  pmid    = {40308118},
  url     = {https://doi.org/10.1002/alz.70173}
}

@article{andersson2025-39939821,
  author  = {Andersson, E. and Lindblom, N. and Janelidze, S. and Salvadó, G. and Gkanatsiou, E. and Söderberg, L. and Möller, C. and Lannfelt, L. and others},
  title   = {{Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer's disease model mice}},
  journal = {Nature aging},
  year    = {2025},
  doi     = {10.1038/s43587-025-00810-8},
  pmid    = {39939821},
  url     = {https://doi.org/10.1038/s43587-025-00810-8}
}

@article{benussi2025-39776166,
  author  = {Benussi, A. and Huber, H. and Tan, K. and Cantoni, V. and Rivolta, J. and Cotelli, M. S. and Benedet, A. L. and Blennow, K. and others},
  title   = {{Plasma p-tau217 and neurofilament/p-tau217 ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2025},
  doi     = {10.1002/alz.14482},
  pmid    = {39776166},
  url     = {https://doi.org/10.1002/alz.14482}
}

@article{weber2024-38595851,
  author  = {Weber, D. M. and Taylor, S. W. and Lagier, R. J. and Kim, J. C. and Goldman, S. M. and Clarke, N. J. and Vaillancourt, D. E. and Duara, R. and others},
  title   = {{Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer's disease assessment}},
  journal = {Frontiers in neurology},
  year    = {2024},
  doi     = {10.3389/fneur.2024.1364658},
  pmid    = {38595851},
  url     = {https://doi.org/10.3389/fneur.2024.1364658}
}

@article{colmant2024-38256246,
  author  = {Colmant, L. and Boyer, E. and Gerard, T. and Sleegers, K. and Lhommel, R. and Ivanoiu, A. and Lefèvre, P. and Kienlen-Campard, P. and others},
  title   = {{Definition of a Threshold for the Plasma Aβ42/Aβ40 Ratio Measured by Single-Molecule Array to Predict the Amyloid Status of Individuals without Dementia}},
  journal = {International journal of molecular sciences},
  year    = {2024},
  doi     = {10.3390/ijms25021173},
  pmid    = {38256246},
  url     = {https://doi.org/10.3390/ijms25021173}
}

@article{liu2023-37695608,
  author  = {Liu, J. and Li, X. and Qu, J.},
  title   = {{Plasma MMP-9/TIMP-1 ratio serves as a novel potential biomarker in Alzheimer's disease}},
  journal = {Neuroreport},
  year    = {2023},
  doi     = {10.1097/wnr.0000000000001952},
  pmid    = {37695608},
  url     = {https://doi.org/10.1097/wnr.0000000000001952}
}

@article{johnson2023-37541842,
  author  = {Johnson, E. L. and Sullivan, K. J. and Schneider, A. L. C. and Simino, J. and Mosley, T. H. and Kucharska-Newton, A. and Knopman, D. S. and Gottesman, R. F.},
  title   = {{Association of Plasma Aβ42/Aβ40 Ratio and Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study}},
  journal = {Neurology},
  year    = {2023},
  doi     = {10.1212/wnl.0000000000207635},
  pmid    = {37541842},
  url     = {https://doi.org/10.1212/wnl.0000000000207635}
}

@article{andersson2023-36964585,
  author  = {Andersson, E. and Schultz, N. and Saito, T. and Saido, T. C. and Blennow, K. and Gouras, G. K. and Zetterberg, H. and Hansson, O.},
  title   = {{Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the AppNL-F/NL-F knock-in mouse model of Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2023},
  doi     = {10.1186/s13195-023-01196-8},
  pmid    = {36964585},
  url     = {https://doi.org/10.1186/s13195-023-01196-8}
}

@article{constantinides2023-36832271,
  author  = {Constantinides, V. C. and Paraskevas, G. P. and Boufidou, F. and Bourbouli, M. and Pyrgelis, E. S. and Stefanis, L. and Kapaki, E.},
  title   = {{CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer's Disease and Frontotemporal Dementias}},
  journal = {Diagnostics (Basel, Switzerland)},
  year    = {2023},
  doi     = {10.3390/diagnostics13040783},
  pmid    = {36832271},
  url     = {https://doi.org/10.3390/diagnostics13040783}
}

@article{liu2023-35278341,
  author  = {Liu, L. and Lauro, B. M. and He, A. and Lee, H. and Bhattarai, S. and Wolfe, M. S. and Bennett, D. A. and Karch, C. M. and others},
  title   = {{Identification of the Aβ37/42 peptide ratio in CSF as an improved Aβ biomarker for Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2023},
  doi     = {10.1002/alz.12646},
  pmid    = {35278341},
  url     = {https://doi.org/10.1002/alz.12646}
}

@article{jang2021-34686209,
  author  = {Jang, H. and Kim, J. S. and Lee, H. J. and Kim, C. H. and Na, D. L. and Kim, H. J. and Allué, J. A. and Sarasa, L. and others},
  title   = {{Performance of the plasma Aβ42/Aβ40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.1186/s13195-021-00911-7},
  pmid    = {34686209},
  url     = {https://doi.org/10.1186/s13195-021-00911-7}
}

@article{shi2020-31336382,
  author  = {Shi, Y. and Gu, L. and Wang, Q. and Gao, L. and Zhu, J. and Lu, X. and Zhou, F. and Zhu, D. and others},
  title   = {{Platelet Amyloid-β Protein Precursor (AβPP) Ratio and Phosphorylated Tau as Promising Indicators for Early Alzheimer's Disease}},
  journal = {The journals of gerontology. Series A, Biological sciences and medical sciences},
  year    = {2020},
  doi     = {10.1093/gerona/glz005},
  pmid    = {31336382},
  url     = {https://doi.org/10.1093/gerona/glz005}
}

@article{qiu2019-30958370,
  author  = {Qiu, Q. and Shen, L. and Jia, L. and Wang, Q. and Li, F. and Li, Y. and Jia, J.},
  title   = {{A Novel PSEN1 M139L Mutation Found in a Chinese Pedigree with Early-Onset Alzheimer's Disease Increases Aβ42/Aβ40 ratio}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2019},
  doi     = {10.3233/jad-181291},
  pmid    = {30958370},
  url     = {https://doi.org/10.3233/jad-181291}
}

@article{santangelo2019-31345148,
  author  = {Santangelo, R. and Dell'Edera, A. and Sala, A. and Cecchetti, G. and Masserini, F. and Caso, F. and Pinto, P. and Leocani, L. and others},
  title   = {{The CSF p-tau181/Aβ42 Ratio Offers a Good Accuracy "In Vivo" in the Differential Diagnosis of Alzheimer's Dementia}},
  journal = {Current Alzheimer research},
  year    = {2019},
  doi     = {10.2174/1567205016666190725150836},
  pmid    = {31345148},
  url     = {https://doi.org/10.2174/1567205016666190725150836}
}

@article{shahpasandkroner2018-30526652,
  author  = {Shahpasand-Kroner, H. and Klafki, H. W. and Bauer, C. and Schuchhardt, J. and Hüttenrauch, M. and Stazi, M. and Bouter, C. and Wirths, O. and others},
  title   = {{A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2018},
  doi     = {10.1186/s13195-018-0448-x},
  pmid    = {30526652},
  url     = {https://doi.org/10.1186/s13195-018-0448-x}
}

@article{koychev2018-30198873,
  author  = {Koychev, I. and Galna, B. and Zetterberg, H. and Lawson, J. and Zamboni, G. and Ridha, B. H. and Rowe, J. B. and Thomas, A. and others},
  title   = {{Aβ42/Aβ40 and Aβ42/Aβ38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer's Disease: A Pilot Study}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2018},
  doi     = {10.3233/jad-180622},
  pmid    = {30198873},
  url     = {https://doi.org/10.3233/jad-180622}
}

@article{tang2018-30412504,
  author  = {Tang, N. and Kepp, K. P.},
  title   = {{Aβ42/Aβ40 Ratios of Presenilin 1 Mutations Correlate with Clinical Onset of Alzheimer's Disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2018},
  doi     = {10.3233/jad-180829},
  pmid    = {30412504},
  url     = {https://doi.org/10.3233/jad-180829}
}

@article{skillback2017-28779628,
  author  = {Skillbäck, T. and Delsing, L. and Synnergren, J. and Mattsson, N. and Janelidze, S. and Nägga, K. and Kilander, L. and Hicks, R. and others},
  title   = {{CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients}},
  journal = {Neurobiology of aging},
  year    = {2017},
  doi     = {10.1016/j.neurobiolaging.2017.06.028},
  pmid    = {28779628},
  url     = {https://doi.org/10.1016/j.neurobiolaging.2017.06.028}
}

@article{siegel2017-28591569,
  author  = {Siegel, G. and Gerber, H. and Koch, P. and Bruestle, O. and Fraering, P. C. and Rajendran, L.},
  title   = {{The Alzheimer's Disease γ-Secretase Generates Higher 42:40 Ratios for β-Amyloid Than for p3 Peptides}},
  journal = {Cell reports},
  year    = {2017},
  doi     = {10.1016/j.celrep.2017.05.034},
  pmid    = {28591569},
  url     = {https://doi.org/10.1016/j.celrep.2017.05.034}
}

@article{pahrudinarrozi2017-28417423,
  author  = {Pahrudin Arrozi, A. and Shukri, S. N. S. and Wan Ngah, W. Z. and Mohd Yusof, Y. A. and Ahmad Damanhuri, M. H. and Makpol, S.},
  title   = {{Evaluation of the Expression of Amyloid Precursor Protein and the Ratio of Secreted Amyloid Beta 42 to Amyloid Beta 40 in SH-SY5Y Cells Stably Transfected with Wild-Type, Single-Mutant and Double-Mutant Forms of the APP Gene for the Study of Alzheimer's Disease Pathology}},
  journal = {Applied biochemistry and biotechnology},
  year    = {2017},
  doi     = {10.1007/s12010-017-2468-6},
  pmid    = {28417423},
  url     = {https://doi.org/10.1007/s12010-017-2468-6}
}

@article{adamczuk2015-26677842,
  author  = {Adamczuk, K. and Schaeverbeke, J. and Vanderstichele, H. M. and Lilja, J. and Nelissen, N. and Van Laere, K. and Dupont, P. and Hilven, K. and others},
  title   = {{Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2015},
  doi     = {10.1186/s13195-015-0159-5},
  pmid    = {26677842},
  url     = {https://doi.org/10.1186/s13195-015-0159-5}
}

@article{slemmon2015-26332787,
  author  = {Slemmon, JR. and Shapiro, A. and Mercken, M. and Streffer, J. and Romano, G. and Andreasen, N. and Zetterberg, H. and Blennow, K.},
  title   = {{Impact of cerebrospinal fluid matrix on the detection of Alzheimer's disease with Aβ42 and influence of disease on the total-Aβ42/Aβ40 ratio}},
  journal = {Journal of neurochemistry},
  year    = {2015},
  doi     = {10.1111/jnc.13297},
  pmid    = {26332787},
  url     = {https://doi.org/10.1111/jnc.13297}
}

@article{wanngren2014-24918054,
  author  = {Wanngren, J. and Lara, P. and Ojemalm, K. and Maioli, S. and Moradi, N. and Chen, L. and Tjernberg, L. O. and Lundkvist, J. and others},
  title   = {{Changed membrane integration and catalytic site conformation are two mechanisms behind the increased Aβ42/Aβ40 ratio by presenilin 1 familial Alzheimer-linked mutations}},
  journal = {FEBS open bio},
  year    = {2014},
  doi     = {10.1016/j.fob.2014.04.006},
  pmid    = {24918054},
  url     = {https://doi.org/10.1016/j.fob.2014.04.006}
}

@article{sauvee2014-24614902,
  author  = {Sauvée, M. and DidierLaurent, G. and Latarche, C. and Escanyé, M. C. and Olivier, J. L. and Malaplate-Armand, C.},
  title   = {{Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2014},
  doi     = {10.3233/jad-131838},
  pmid    = {24614902},
  url     = {https://doi.org/10.3233/jad-131838}
}

@article{beaufils2013-22986776,
  author  = {Beaufils, E. and Dufour-Rainfray, D. and Hommet, C. and Brault, F. and Cottier, J. P. and Ribeiro, M. J. and Mondon, K. and Guilloteau, D.},
  title   = {{Confirmation of the amyloidogenic process in posterior cortical atrophy: value of the Aβ42/Aβ40 ratio}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2013},
  doi     = {10.3233/jad-2012-121267},
  pmid    = {22986776},
  url     = {https://doi.org/10.3233/jad-2012-121267}
}

@article{murray2012-22429885,
  author  = {Murray, P. S. and Kirkwood, C. M. and Gray, M. C. and Ikonomovic, M. D. and Paljug, W. R. and Abrahamson, E. E. and Henteleff, R. A. and Hamilton, R. L. and others},
  title   = {{β-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis}},
  journal = {Neurobiology of aging},
  year    = {2012},
  doi     = {10.1016/j.neurobiolaging.2012.02.015},
  pmid    = {22429885},
  url     = {https://doi.org/10.1016/j.neurobiolaging.2012.02.015}
}